Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar;47(3):135-40.
doi: 10.5483/bmbrep.2014.47.3.289.

The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy

Eun Young Kim  1 , Kyung-Bon Lee  2 , Min Kyu Kim  1
Affiliations
Review

The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy

Eun Young Kim et al. BMB Rep. 2014 Mar.

Abstract

The mesenchymal stem cells (MSCs), which are derived from the mesoderm, are considered as a readily available source for tissue engineering. They have multipotent differentiation capacity and can be differentiated into various cell types. Many studies have demonstrated that the MSCs identified from amniotic membrane (AM-MSCs) and amniotic fluid (AF-MSCs) are shows advantages for many reasons, including the possibility of noninvasive isolation, multipotency, self-renewal, low immunogenicity, anti-inflammatory and nontumorigenicity properties, and minimal ethical problem. The AF-MSCs and AM-MSCs may be appropriate sources of mesenchymal stem cells for regenerative medicine, as an alternative to embryonic stem cells (ESCs). Recently, regenerative treatments such as tissue engineering and cell transplantation have shown potential in clinical applications for degenerative diseases. Therefore, amnion and MSCs derived from amnion can be applied to cell therapy in neuro-degeneration diseases. In this review, we will describe the potential of AM-MSCs and AF-MSCs, with particular focus on cures for neuronal degenerative diseases.

PubMed Disclaimer

References

    1. Ryu H. H, Lim J. H., Byeon Y. E., Park J. R., Seo M. S., Lee Y. W., Kim W. H., Kang K. S., Kweon O. K. Functional recovery and neural differentiation after transplantation of allogenic adipose-derived stem cells in a canine model of acute spinal cord injury. J. Vet. Sci. (2009);10:273–284. doi: 10.4142/jvs.2009.10.4.273. - DOI - PMC - PubMed
    1. Payushina O. V., Domaratskaya E. L., Starostin V. I. Mesenchymal stem cells: Sources, phenotype, and differentiation potential. Biology Bulletin. (2006);33:2–18. doi: 10.1134/S106235900601002X. - DOI - PubMed
    1. Choi S. A., Choi H. S., Kim K. J., Lee D. S., Lee J. H., Park J. Y., Kim E. Y., Li X., Oh H. Y., Lee D. S., Kim M. K. Isolation of canine mesenchymal stem cells from amniotic fluid and differentiation into hepatocyte-like cells. In. Vitro. Cell Dev. Biol. Anim. (2013);49:42–51. doi: 10.1007/s11626-012-9569-x. - DOI - PubMed
    1. Barzilay R., Kan I., Ben-Zur T., Bulvik S., Melamed E., Offen D. Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols. Stem Cells and Development. (2008);17:547–554. doi: 10.1089/scd.2007.0172. - DOI - PubMed
    1. Carraro G., Perin L., Sedrakyan S., Giuliani S., Tiozzo C., Lee J., Turcatel G., De Langhe S. P., Driscoll B., Bellusci S., Minoo P., Atala A., De Filippo R. E., Warburton D. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem. Cells. (2008);26:2902–2911. doi: 10.1634/stemcells.2008-0090. - DOI - PMC - PubMed

Publication types

MeSH terms